Indraprastha Medical Corporation Hits New 52-Week High of Rs. 607.4

Indraprastha Medical Corporation has reached a significant milestone by hitting a new 52-week high of Rs. 607.4 on October 8, 2025. This achievement marks a notable increase of 5.86% during the trading session, contributing to a remarkable 35.61% rise over the past six days. The stock has consistently outperformed its sector, showcasing a performance that is 3.82% above the industry average.
In terms of financial health, Indraprastha Medical Corporation has demonstrated strong management efficiency, reflected in a high return on equity (ROE) of 18.90%. The company maintains a low debt-to-equity ratio, indicating a solid balance sheet. Over the past year, the company has reported a 47.96% increase in stock value, significantly outpacing the Sensex, which has seen a modest gain of 0.71%.

The company has also shown impressive operational growth, with operating profit growing at an annual rate of 106.49%. With positive results reported for the last 13 consecutive quarters, Indraprastha Medical Corporation continues to solidify its position in the hospital industry as a small-cap leader.